Cancer drug attacking cancer cells. 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round). Cetuximab is a chemotherapy drug, used to treat metastatic colon cancer. It acts by inhibiting epidermal growth factor receptor (EGFR), therefore blocking the signals that tell the cancer cells to grow and divide.
Delhi’s Lok Nayak Jai Prakash Narayan Hospital (LNJP) ahad begun Monoclonal Antibody Cocktail used to treat mild to moderate “high risk” patients who are Covid positive, free of cost.
“We have received a Monoclonal Antibody Cocktail– a combination of Casirivimab and Imdevimab. We have started using it in LNJP hospital. Now we will be able to provide the latest medicines for the Covid-19 patients. These are the monoclonal antibodies and they are very useful,” said Dr Suresh Kumar, Managing Director, LNJP hospital”We will have first-time experience of these drug cocktails or antibody cocktails.
Earlier patients were going to the private hospitals to get this treatment, but now the government has made a provision and we are giving it in LNJP. We are giving it free of cost.”Roche India and Cipla had announced the launch of the Antibody Cocktail in India last week.
Priced at ₹59,750 for a dose, the therapy has been earlier introduced in private hospitals Fortis Escorts, Moolchand, Apollo, Sir Gangaram, and Max Hospital.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…